Carlos Grijalva
Last active: 7/27/2018

  1. Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009. Self WH, Grijalva CG, Zhu Y, McNaughton CD, Barrett TW, Collins SP, Storrow AB, Griffin MR (2013) Acad Emerg Med 20(9): 957-60
    › Primary publication · 24033659 (PubMed) · PMC3907184 (PubMed Central)
  2. Panel 6: Vaccines. Pelton SI, Pettigrew MM, Barenkamp SJ, Godfroid F, Grijalva CG, Leach A, Patel J, Murphy TF, Selak S, Bakaletz LO (2013) Otolaryngol Head Neck Surg 148(4 Suppl): E90-101
    › Primary publication · 23536534 (PubMed) · PMC4029613 (PubMed Central)
  3. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee. Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W (2013) Pediatr Infect Dis J 32(6): 604-9
    › Primary publication · 23348816 (PubMed)
  4. Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia. Williams DJ, Hall M, Shah SS, Parikh K, Tyler A, Neuman MI, Hersh AL, Brogan TV, Blaschke AJ, Grijalva CG (2013) Pediatrics 132(5): e1141-8
    › Primary publication · 24167170 (PubMed) · PMC4530302 (PubMed Central)
  5. Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children. Ferolla FM, Hijano DR, Acosta PL, Rodríguez A, Dueñas K, Sancilio A, Barboza E, Caría A, Gago GF, Almeida RE, Castro L, Pozzolo C, Martínez MV, Grimaldi LA, Rebec B, Calvo M, Henrichsen J, Nocito C, González M, Barbero G, Losada JV, Caballero MT, Zurankovas V, Raggio M, Schavlovsky G, Kobylarz A, Wimmenauer V, Bugna J, Williams JV, Sastre G, Flamenco E, Pérez AR, Ferrero F, Libster R, Grijalva CG, Polack FP (2013) Am J Respir Crit Care Med 187(9): 983-90
    › Primary publication · 23449690 (PubMed)
  6. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control. Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG, Murff HJ, Griffin MR (2013) Pharmacoepidemiol Drug Saf 22(6): 623-31
    › Primary publication · 23592561 (PubMed) · PMC4887572 (PubMed Central)
  7. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF, Stein CM, Griffin MR (2013) Arthritis Care Res (Hoboken) 65(7): 1085-94
    › Primary publication · 23281339 (PubMed) · PMC3631448 (PubMed Central)
  8. Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Winthrop KL, Chen L, Fraunfelder FW, Ku JH, Varley CD, Suhler E, Hills WL, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton LJ, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR (2013) Am J Ophthalmol 155(1): 183-189.e1
    › Primary publication · 22967869 (PubMed) · PMC4142597 (PubMed Central)
  9. Hospitalizations after a decade of pneumococcal vaccination. Griffin MR, Grijalva CG (2013) N Engl J Med 369(17): 1662-3
    › Primary publication · 24152270 (PubMed)
  10. Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children. Sakai F, Talekar SJ, Lanata CF, Grijalva CG, Klugman KP, Vidal JE, RESPIRA PERU Group, Investigators Group (2013) PLoS One 8(6): e67147
    › Primary publication · 23825636 (PubMed) · PMC3688971 (PubMed Central)